From pathogenetic point of view, in IPF patients AT2 cells was shown to release fibrogenic factors and cytokine (including monocyte chemoattractant protein-1 (MCP-1), TGF-β1, TNF-α, IL-1β, and IL-6). This evidence concerns the gene TNF and idiopathic pulmonary fibrosis.